115 related articles for article (PubMed ID: 38272344)
21. Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study.
Cabibbo G; Maida M; Genco C; Parisi P; Peralta M; Antonucci M; Brancatelli G; Cammà C; Craxì A; Di Marco V
World J Hepatol; 2012 Sep; 4(9):256-61. PubMed ID: 23060970
[TBL] [Abstract][Full Text] [Related]
22. Validation and ranking of seven staging systems of hepatocellular carcinoma.
Chen ZH; Hong YF; Lin J; Li X; Wu DH; Wen JY; Chen J; Ruan DY; Lin Q; Dong M; Wei L; Wang TT; Lin ZX; Ma XK; Wu XY; Xu R
Oncol Lett; 2017 Jul; 14(1):705-714. PubMed ID: 28693224
[TBL] [Abstract][Full Text] [Related]
23. Prospective validation of the Barcelona Clinic Liver Cancer staging system.
Cillo U; Vitale A; Grigoletto F; Farinati F; Brolese A; Zanus G; Neri D; Boccagni P; Srsen N; D'Amico F; Ciarleglio FA; Bridda A; D'Amico DF
J Hepatol; 2006 Apr; 44(4):723-31. PubMed ID: 16488051
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
Zhang JF; Shu ZJ; Xie CY; Li Q; Jin XH; Gu W; Jiang FJ; Ling CQ
PLoS One; 2014; 9(3):e88182. PubMed ID: 24609114
[TBL] [Abstract][Full Text] [Related]
25. Prognostic nomograms for HBV-related BCLC 0-a stage hepatocellular carcinoma incorporating aspartate aminotransferase to albumin ratio.
Wu Y; Peng W; Shen J; Zhang X; Li C; Wen TF
Scand J Gastroenterol; 2023 Jul; 58(7):789-797. PubMed ID: 36620916
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization.
Zhong BY; Jiang JQ; Sun JH; Huang JT; Wang WD; Wang Q; Ding WB; Zhu XL; Ni CF
J Clin Transl Hepatol; 2023 Nov; 11(6):1321-1328. PubMed ID: 37719966
[TBL] [Abstract][Full Text] [Related]
27. Ideal patients for liver resection in Barcelona Clinic Liver Cancer or Hong Kong Liver clinic systems for hepatocellular carcinoma: Conservative or aggressive?
Li JX; Zhou P; Chang DH; Tong Y; Bao Y; Xiao YD; Zhou S; Cai WW
Front Med (Lausanne); 2022; 9():977135. PubMed ID: 36314035
[TBL] [Abstract][Full Text] [Related]
28. Validation of the BCLC prognostic system in surgical hepatocellular cancer patients.
Vitale A; Saracino E; Boccagni P; Brolese A; D'Amico F; Gringeri E; Neri D; Srsen N; Valmasoni M; Zanus G; Carraro A; Violi P; Pauletto A; Bassi D; Polacco M; Burra P; Farinati F; Feltracco P; Romano A; D'Amico DF; Cillo U
Transplant Proc; 2009 May; 41(4):1260-3. PubMed ID: 19460533
[TBL] [Abstract][Full Text] [Related]
29. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study.
Borzio M; Dionigi E; Rossini A; Marignani M; Sacco R; De Sio I; Bertolini E; Francica G; Giacomin A; Parisi G; Vicari S; Toldi A; Salmi A; Boccia S; Mitra M; Fornari F
Hepatology; 2018 Jun; 67(6):2215-2225. PubMed ID: 29165831
[TBL] [Abstract][Full Text] [Related]
30. Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
Tsilimigras DI; Bagante F; Sahara K; Moris D; Hyer JM; Wu L; Ratti F; Marques HP; Soubrane O; Paredes AZ; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2019 Oct; 26(11):3693-3700. PubMed ID: 31267302
[TBL] [Abstract][Full Text] [Related]
31. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria.
Wang YY; Zhong JH; Xu HF; Xu G; Wang LJ; Xu D; Wang HW; Wang K; Xiang BD; Mao YL; Li LQ; Xing BC
Aliment Pharmacol Ther; 2019 Jan; 49(2):202-210. PubMed ID: 30506713
[TBL] [Abstract][Full Text] [Related]
32. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
[TBL] [Abstract][Full Text] [Related]
33. Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system.
Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Lee FY; Huo TI
Hepatology; 2013 Jan; 57(1):112-9. PubMed ID: 22806819
[TBL] [Abstract][Full Text] [Related]
34. Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.
Jun CH; Yoon JH; Cho E; Shin SS; Cho SB; Kim HJ; Park CH; Kim HS; Choi SK; Rew JS
Medicine (Baltimore); 2017 Apr; 96(17):e6745. PubMed ID: 28445298
[TBL] [Abstract][Full Text] [Related]
35. Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Lee PC; Loong CC; Chiang JH; Huo TI; Lee SD
Cancer; 2010 Jun; 116(12):3006-14. PubMed ID: 20564406
[TBL] [Abstract][Full Text] [Related]
36. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma staging systems: Hong Kong liver cancer
de Freitas LBR; Longo L; Santos D; Grivicich I; Álvares-da-Silva MR
World J Hepatol; 2019 Sep; 11(9):678-688. PubMed ID: 31602288
[TBL] [Abstract][Full Text] [Related]
38. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort.
Adhoute X; Pénaranda G; Raoul JL; Edeline J; Blanc JF; Pol B; Campanile M; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Le Treut YP; Bronowicki JP; Bourlière M
World J Gastroenterol; 2017 Apr; 23(14):2545-2555. PubMed ID: 28465639
[TBL] [Abstract][Full Text] [Related]
39. How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?
Lee YJ; Lee YR; Seo CG; Goh HG; Kim TH; Yim SY; Han NY; Lee JM; Choi HS; Kim ES; Keum B; An H; Park B; Seo YS; Yim HJ; Kim JH; Yu YD; Kim DS; Jeen YT; Chun HJ; Lee HS; Kim CD; Um SH
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32927918
[TBL] [Abstract][Full Text] [Related]
40. Artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma.
Qiao G; Li J; Huang A; Yan Z; Lau WY; Shen F
J Gastroenterol Hepatol; 2014 Dec; 29(12):2014-20. PubMed ID: 24989634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
